Detalles de la búsqueda
1.
In vitro and in vivo studies of a potent capsid-binding inhibitor of enterovirus 71.
J Antimicrob Chemother
; 71(7): 1922-32, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27098012
2.
Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors.
Bioorg Med Chem
; 18(17): 6414-21, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20675142
3.
Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
Bioorg Med Chem Lett
; 19(15): 4134-8, 2009 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19539472
4.
Design and efficient synthesis of novel arylthiourea derivatives as potent hepatitis C virus inhibitors.
Bioorg Med Chem Lett
; 19(21): 6063-8, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19796940
5.
A novel, potent, and orally bioavailable thiazole HCV NS5A inhibitor for the treatment of hepatitis C virus.
Eur J Med Chem
; 167: 245-268, 2019 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30772607
6.
A Potent, Selective, and Orally Bioavailable HCV NS5A Inhibitor for Treatment of Hepatitis C Virus: (S)-1-((R)-2-(Cyclopropanecarboxamido)-2-phenylacetyl)-N-(4-phenylthiazol-2-yl)pyrrolidine-2-carboxamide.
J Med Chem
; 60(1): 228-247, 2017 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27966956
Resultados
1 -
6
de 6
1
Próxima >
>>